Generic Drug Trust Rebuilding / 仿制药再信任

Generic drug trust rebuilding is the episode’s explanation for why low price alone did not make Japanese patients accept generics. In vol.120.日本医疗体系的崩溃与重生：医院、药品、医保三角困局的一种解法, the first low-price cycle damaged quality and public confidence, so later substitution required better quality, different pricing, pharmacy involvement, and industry clearing.

The source treats generic substitution as a social and professional trust problem. Patients need to believe that a cheaper drug is not inferior, and that belief is easier to build when [[PharmacistAsSecondDoctor|pharmacists]] can explain medication choices and monitor ongoing use.

Key Claims

• Generic-drug uptake depends on quality credibility, not only insurance incentives.
• Excessive low-price competition can create adverse selection among manufacturers.
• Trust rebuilding requires a visible professional interface between patient, doctor, pharmacy, and insurer.

Connections

• Japanese Drug Pricing Reform / 日本药品定价改革 - pricing and industry-policy background.
• Pharmacist As Second Doctor / 药剂师第二医生体系 - professional role that helps substitution work.
• Japanese Healthcare System / 日本医疗体系 - broader insurance and care context.
• Pharmaceutical Ecommerce and Internet Healthcare - adjacent drug-access branches in the wiki.